Increased phospholipase D activity in human breast cancer

被引:33
|
作者
Uchida, N
Okamura, S
Nagamachi, Y
Yamashita, S
机构
[1] GUNMA UNIV,SCH MED,DEPT BIOCHEM,MAEBASHI,GUMMA 371,JAPAN
[2] GUNMA UNIV,SCH MED,DEPT SURG 1,MAEBASHI,GUMMA 371,JAPAN
关键词
phospholipase D; breast tumor; phosphatidylcholine; phosphatidylethanol;
D O I
10.1007/BF01208639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phospholipase D is believed to play an important role in cell proliferation and tumorigenesis. One of its major functions is to cause a sustained activation of protein kinase C through the primary production of phosphatidic acid from phosphatidylcholine by the enzyme, followed by dephosphorylation forming diacylglycerol. Protein kinase C is known to be activated or translocated in some tumors including breast turners, In order to examine phospholipase D activity ill breast rumors, surgical specimens of human breast tumors were obtained by mastectomy or wide excision, and their phospholipase D activities were assayed by determining the formation of phosphatidylethanol from phosphatidylcholine and ethanol. Phospholipase D activity was predominantly localized in the microsomal fraction of the tumor tissue and markedly stimulated by oleic acid. We observed a significant increase in phospholipase D activity in 17 out of 19 spontaneous human breast tumors as compared to adjacent histologically normal breast tissue. The mean specific activity in the tumors was 52.9 +/- 41.8 (SD) pmol min(-1) mg protein(-1) whereas the value for the normal breast tissue was 34.0 +/- 36.2 (SD) pmol min(-1) mg protein(-1) (P < 0.01; paired Wilcoxon's rank-sum test). The mean tumor/normal activity ratio was 2.37. Among prognostic factors, the nuclear grade, evaluated according to Schnitt et al., was found to be correlated with the activity ratio. Our results suggest a role for phospholipase D in human breast tumors, An elevation in phospholipase D activity is useful as a potential marker for malignant disease in the breast.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 50 条
  • [21] Increased levels of methylated intermediates of phosphatidylcholine lead to enhanced phospholipase D activity
    Jacobs, TQ
    Passarello, B
    Horwitz, J
    NEUROCHEMICAL RESEARCH, 1998, 23 (08) : 1099 - 1105
  • [22] Increased Levels of Methylated Intermediates of Phosphatidylcholine Lead to Enhanced Phospholipase D Activity
    Thomas Q. Jacobs
    Brent Passarello
    Joel Horwitz
    Neurochemical Research, 1998, 23 : 1099 - 1105
  • [23] Role and regulation of phospholipase D activity in normal and cancer cells
    Wakelam, MJO
    Martin, A
    Hodgkin, MN
    Brown, F
    Pettitt, TR
    Cross, MJ
    DeTakats, PG
    Reynolds, JL
    ADVANCES IN ENZYME REGULATION, VOL 37, 1997, 37 : 29 - 34
  • [24] Abberations in phospholipase D activity - A pharmacological target for cancer detection
    Chia, PH
    Kenney, PJ
    Weichert, JP
    Weber, SM
    Longino, MA
    FASEB JOURNAL, 2006, 20 (04): : A488 - A488
  • [25] Inhibition of phorbol ester-stimulated phospholipase D activity by chronic tamoxifen treatment in breast cancer cells
    Kiss, Z
    Anderson, WH
    FEBS LETTERS, 1997, 400 (02) : 145 - 148
  • [26] Estrogen, phospholipase A and breast cancer
    Thomas, Warren
    Caiazza, Francesco
    Harvey, Brian J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 2604 - 2613
  • [27] Phospholipase Signaling in Breast Cancer
    Lee, Yu Jin
    Shin, Kyeong Jin
    Jang, Hyun-Jun
    Noh, Dong-Young
    Ryu, Sung Ho
    Suh, Pann-Ghill
    TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 23 - 52
  • [28] CHARACTERIZATION OF PHOSPHOLIPASE-A2 ACTIVITY IN MDA-MB-435 HUMAN BREAST-CANCER CELLS
    HATALA, MA
    RAYBURN, J
    ROSE, DP
    CANCER LETTERS, 1993, 72 (1-2) : 31 - 37
  • [29] Vitamin D Analogs Enhance the Anastrozole Activity in Human Breast Cancer Models
    Filip, B.
    Libako, P.
    Kutner, A.
    Wietrzyk, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S361 - S361
  • [30] Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model
    Henkels, K. M.
    Boivin, G. P.
    Dudley, E. S.
    Berberich, S. J.
    Gomez-Cambronero, J.
    ONCOGENE, 2013, 32 (49) : 5551 - 5562